GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zoetis Inc (FRA:ZOE) » Definitions » Other Long Term Assets

Zoetis (FRA:ZOE) Other Long Term Assets : €422 Mil (As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Zoetis Other Long Term Assets?

Zoetis's other long-term assets for the quarter that ended in Mar. 2024 was €422 Mil.

Zoetis's quarterly other long-term assets declined from Sep. 2023 (€380 Mil) to Dec. 2023 (€378 Mil) but then increased from Dec. 2023 (€378 Mil) to Mar. 2024 (€422 Mil).

Zoetis's annual other long-term assets increased from Dec. 2021 (€187 Mil) to Dec. 2022 (€302 Mil) and increased from Dec. 2022 (€302 Mil) to Dec. 2023 (€378 Mil).

Zoetis Other Long Term Assets Historical Data

The historical data trend for Zoetis's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zoetis Other Long Term Assets Chart

Zoetis Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 167.40 164.40 186.74 302.08 377.80

Zoetis Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 283.94 336.90 380.42 377.80 422.28

Zoetis Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Zoetis (FRA:ZOE) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zoetis Inc (FRA:ZOE) » Definitions » Other Long Term Assets
Comparable Companies
VTRS NBIX CTLT ITCI ELAN LNTH ALKS PRGO PBH ALVO XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692 NSE:DIVISLAB
Traded in Other Exchanges
ZTS:USA ZTS:Mexico 1ZTS:Italy ZOE:Germany ZOE:Germany Z1TS34:Brazil
Address
10 Sylvan Way, Parsippany, NJ, USA, 07054
Website
https://www.zoetis.com
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Zoetis (FRA:ZOE) Headlines

No Headlines